“Another Tuskegee”: Leaked Docs Reveal CDC Is Funding Deadly Study

The health newsletter Inside Medicine obtained the protocols for a study receiving $1.6 million to experiment on babies in Guinea-Bissau. The experiment is a “randomized controlled trial to assess the effects of neonatal Hepatitis B vaccination on early-life mortality, morbidity, and long-term developmental outcomes,” according to a Federal Register notice. 

The comparisons to Tuskegee, an experiment in which the U.S. government let syphilis go unchecked in African Americans in Alabama from 1932 to 1972, came from an unnamed CDC official who spoke to Inside Medicine. 

“This is another Tuskegee,” the official said. “We are allowing children, infants, to be exposed to Hepatitis B when we could prevent it, and then follow them for five years to see what happens. That’s not long enough to see the long-term benefits, but might be long enough to find some non-specific effects.”